Navigation Links
AlloSource Joins Alliance for Regenerative Medicine, Medical Device Manufacturers Association
Date:8/9/2011

CENTENNIAL, Colo., Aug. 9, 2011 /PRNewswire/ -- AlloSource, a leading developer, processor and distributor of bone and soft-tissue allografts for use in surgical procedures around the world, today announced two new key affiliations with the Alliance for Regenerative Medicine (ARM) and the Medical Device Manufacturers Association (MDMA).  AlloSource pursued membership with both organizations in order to support medical device and regenerative medicine grassroots efforts with policy makers.

ARM is a nonprofit whose mission is to educate key policy makers about the potential of regenerative medicine and to advocate for favorable public policies to facilitate advances in the field. MDMA is a national trade association providing educational and advocacy assistance to innovative and entrepreneurial medical technology companies.  Both organizations have already made progress in growing the knowledge base of Capitol Hill influencers on the current industry issues that affect their member organizations.

"AlloSource honors the gift of life from donors and their families by safely and respectfully processing donated tissue, and because of this we are dedicated to expanding the medical possibilities of tissue transplantation," Thomas Cycyota, AlloSource President and CEO.  "We look forward to working with the Alliance for Regenerative Medicine and the Medical Device Manufacturers Association to educate regulators on the ways regenerative medicine and medical devices using donated tissue do and will continue to greatly improve the quality of life for millions of patients in need."

AlloSource recently expanded its product offerings with the addition of AlloStem® Stem Cell Bone Growth Substitute, which pioneers the use of mesenchymal stem cells derived from donor adipose tissue for orthopedic applications, helping to stimulate natural bone formation. Through the osteobiologics products they produce, the company has facilitated approximat
'/>"/>

SOURCE AlloSource
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Medical Device Industry Veteran Angela Horacek Joins AlloSource as VP of Operations
2. AlloSource Named Colorados Top Healthcare Company
3. AlloSource and Partners Provide Life-Saving Burn Treatment to Haitian Earthquake Survivors
4. AlloSource Sponsors Heroic Quadruple Amputee as Rider Aboard 2010 Donate Life Rose Parade Float
5. Michael Showalter Joins Prime Therapeutics As Chief Marketing Officer
6. Timothy Cote, MD, MPH, Joins NORD as Chief Medical Officer
7. INTENSA Medical Furniture Joins Attainia
8. Sol J. Barer, Ph.D. Joins InspireMD Board of Directors
9. Genetix Joins Molecular Devices: Combining Businesses to be in a Better Position to Serve Customers
10. Bacterin Joins Russell 3000, Russell Microcap, and Russell Global Indexes
11. Drs. Ben Machielse Joins Omthera Pharmaceuticals, Inc. as Chief Operating Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... 2015  Rosa & Co. LLC, a drug development ... today announced its pleasure to be lead partner for ... Systems Pharmacology (QSP). The conference focuses on uses and ... Logo - ... Rosa,s lead sponsorship is the second of ...
(Date:4/28/2015)... -- Boston Scientific Corporation (NYSE: BSX ) generated ... ended March 31, 2015, compared to the company,s ... $1.800 billion.  This represents 6 percent operational revenue ... flat revenue on a reported basis, all compared ... adjusted earnings per share of $0.21 for the ...
(Date:4/28/2015)... INDIANAPOLIS , April 28, 2015  People with ... receive a heart stent are prescribed an oral antiplatelet (OAP) ... blood clot in their heart stent (stent thrombosis), or even ... that 52 percent of 275 ACS patients who were currently ... they take their prescribed OAP therapy, even though most of ...
Breaking Medicine Technology:Rosa & Co. is the Lead Partner for the Quantitative Systems Pharmacology (QSP) Congress in Basel, Switzerland and Will Present the Keynote Address 2Rosa & Co. is the Lead Partner for the Quantitative Systems Pharmacology (QSP) Congress in Basel, Switzerland and Will Present the Keynote Address 3Boston Scientific Announces Results for First Quarter 2015 2Boston Scientific Announces Results for First Quarter 2015 3Boston Scientific Announces Results for First Quarter 2015 4Boston Scientific Announces Results for First Quarter 2015 5Boston Scientific Announces Results for First Quarter 2015 6Boston Scientific Announces Results for First Quarter 2015 7Boston Scientific Announces Results for First Quarter 2015 8Boston Scientific Announces Results for First Quarter 2015 9Boston Scientific Announces Results for First Quarter 2015 10Boston Scientific Announces Results for First Quarter 2015 11Boston Scientific Announces Results for First Quarter 2015 12Boston Scientific Announces Results for First Quarter 2015 13Boston Scientific Announces Results for First Quarter 2015 14Boston Scientific Announces Results for First Quarter 2015 15Boston Scientific Announces Results for First Quarter 2015 16Boston Scientific Announces Results for First Quarter 2015 17Boston Scientific Announces Results for First Quarter 2015 18Boston Scientific Announces Results for First Quarter 2015 19Boston Scientific Announces Results for First Quarter 2015 20Boston Scientific Announces Results for First Quarter 2015 21Boston Scientific Announces Results for First Quarter 2015 22Boston Scientific Announces Results for First Quarter 2015 23Boston Scientific Announces Results for First Quarter 2015 24Boston Scientific Announces Results for First Quarter 2015 25Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 2Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 3Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 4Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 5Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 6Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 7Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 8Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 9
... ... ... ... ...
... ... ... ... ...
Cached Medicine Technology:DATATRAK Attends 22nd Annual DIA EuroMeeting in Monaco 2DATATRAK Attends 22nd Annual DIA EuroMeeting in Monaco 3DATATRAK Attends 22nd Annual DIA EuroMeeting in Monaco 4DATATRAK Attends 22nd Annual DIA EuroMeeting in Monaco 5DATATRAK Attends 22nd Annual DIA EuroMeeting in Monaco 6HIMSS Honors Memorial Healthcare System for Using TheraDoc(TM) Decision Support Technology to Achieve 97 Percent Compliance With Pediatric Asthma Quality Measures 2HIMSS Honors Memorial Healthcare System for Using TheraDoc(TM) Decision Support Technology to Achieve 97 Percent Compliance With Pediatric Asthma Quality Measures 3HIMSS Honors Memorial Healthcare System for Using TheraDoc(TM) Decision Support Technology to Achieve 97 Percent Compliance With Pediatric Asthma Quality Measures 4HIMSS Honors Memorial Healthcare System for Using TheraDoc(TM) Decision Support Technology to Achieve 97 Percent Compliance With Pediatric Asthma Quality Measures 5HIMSS Honors Memorial Healthcare System for Using TheraDoc(TM) Decision Support Technology to Achieve 97 Percent Compliance With Pediatric Asthma Quality Measures 6HIMSS Honors Memorial Healthcare System for Using TheraDoc(TM) Decision Support Technology to Achieve 97 Percent Compliance With Pediatric Asthma Quality Measures 7
(Date:4/28/2015)... April 28, 2015 2015 Market ... is a professional and in-depth research report. The ... application, industry overview, industry chain structure, international market ... covers the global (US, Europe, Japan, Asia) and ... macroeconomic environment & economic situation analysis. The Global ...
(Date:4/28/2015)... biologics safety testing market is growing at a favorable ... of the pharmaceutical and biological industries and an increasing ... number of drug approvals in North American countries has ... drug applications and Health Canada approved 99. In addition, ... pharmaceutical and 1,998 of the biotechnology patents granted in ...
(Date:4/28/2015)... Pittsburgh, PA (PRWEB) April 28, 2015 ... by Blair A. Jobe, MD, FACS , has ... replacing esophageal tissue with extracellular matrix (ECM) can help ... lethal form of esophageal cancer. , ECM is a ... for cell attachment and migration and signals that guide ...
(Date:4/28/2015)... 28, 2015 A first-in-human prostate ... Molecular Imaging and Biology showed initial safety, biodistribution, ... fluorine-18 labeled small-molecule PSMA inhibitor. The imaging biomarker ... Baltimore, MD by study co-author, Martin G. Pomper, ... of [18F]DCFPyL demonstrated a number of important findings. ...
(Date:4/28/2015)... 2015 The buyer power score for ... 5, indicating a medium level of buyer power in ... have equal power during negotiations. One factor helping buyer ... a health insurance policy from an insurance carrier (such ... can choose to self-fund their own policy or forgo ...
Breaking Medicine News(10 mins):Health News:Centrifuges Market 2015 Global Research Report 2Health News:Centrifuges Market 2015 Global Research Report 3Health News:Biological Safety Testing Market, By Application Product & Test – Global Forecast 2019 - Report Released by MarketsandMarkets 2Health News:Biological Safety Testing Market, By Application Product & Test – Global Forecast 2019 - Report Released by MarketsandMarkets 3Health News:Biological Safety Testing Market, By Application Product & Test – Global Forecast 2019 - Report Released by MarketsandMarkets 4Health News:Allegheny Health Network Launches First U.S. Clinical Trial of Extracellular Matrix as Replacement for Pre-Cancerous Tissue 2Health News:Allegheny Health Network Launches First U.S. Clinical Trial of Extracellular Matrix as Replacement for Pre-Cancerous Tissue 3Health News:Second Generation 18F-labeled Prostate-Specific Membrane Antigen (PSMA) Targeted Imaging Agent Found to be Highly Sensitive in Detecting Prostate Cancer 2Health News:Second Generation 18F-labeled Prostate-Specific Membrane Antigen (PSMA) Targeted Imaging Agent Found to be Highly Sensitive in Detecting Prostate Cancer 3Health News:New Data for Group Health Insurance Procurement Category Market Research Report from IBISWorld 2Health News:New Data for Group Health Insurance Procurement Category Market Research Report from IBISWorld 3Health News:New Data for Group Health Insurance Procurement Category Market Research Report from IBISWorld 4
... strain is similar to that seen in 1918, with ... 24 (HealthDay News) -- The 2009 H1N1 "swine flu" ... early in the 20th century, two teams of scientists ... people seemed to be less affected by H1N1 during ...
... Tuesday, President Obama signed into law U.S. health care ... affect them, their families, and businesses. The ... 2006 legislation in Massachusetts requiring all adults in the ... mandate. A new article from The Milbank Quarterly ...
... , ... Another Group Logic Solution to Their Product Portfolio , ... (PRWEB) March 24, 2010 -- Group Logic, the ... the United Kingdom, Jigsaw Systems, is adding the MassTransit product line to its solution ...
... ... solution will power health information exchange across LSU hospital system for more than 2800 ... ... will be able to access patient information across the 10 rural and metropolitan hospitals ...
... This release is available in Spanish . ... area as the original tumour remains the strongest, independent prognostic ... have been free of disease for a very long time, ... Breast Cancer Conference (EBCC7). Dr Sven Mieog, MD, a ...
... - Despite the aches and pains that occur in old ... positive experiences from their past. A new study, reported ... ( http://www.elsevier.com/locate/cortex ), reveals that older adults, ability to remember ... way in which the brain processes emotional content. In ...
Cached Medicine News:Health News:H1N1 Virus Yields Up More Secrets 2Health News:Massachusetts health care reform reviewed as a model for national plan 2Health News:Jigsaw Systems to Deliver Group Logic's MassTransit Solution for Managed File Transfer 2Health News:Carefx Portal Solution to Deliver First Time, Statewide Access to Patient Data Among Hospitals in the LSU Network 2Health News:Carefx Portal Solution to Deliver First Time, Statewide Access to Patient Data Among Hospitals in the LSU Network 3Health News:Carefx Portal Solution to Deliver First Time, Statewide Access to Patient Data Among Hospitals in the LSU Network 4Health News:Recurrence of breast cancer after more than 10 years is an important indicator of survival 2Health News:Recurrence of breast cancer after more than 10 years is an important indicator of survival 3Health News:Older adults remember the good times 2
The under-patient design of the pediatric full access blanket warms even the tiniest patients while allowing full access for surgeons and staff....
Similar to Model 530, but just 37 inches long and with only one drape....
This pediatric blanket is a smaller version of the full body blanket, providing warmth to smaller patients during recovery....
2-ply material consisting of polyethylene film inner layer and non-woven outer layers....
Medicine Products: